We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,603 results
  1. Oligodendrocyte death initiates synchronous remyelination to restore cortical myelin patterns in mice

    Myelin degeneration occurs in neurodegenerative diseases and aging. In these conditions, resident oligodendrocyte progenitor cells (OPCs)...

    Timothy W. Chapman, Genaro E. Olveda, ... Robert A. Hill in Nature Neuroscience
    Article 16 March 2023
  2. Features of Remyelination after Transplantation of Olfactory Ensheathing Cells with Neurotrophic Factors into Spinal Cord Cysts

    This paper shows for the first time that co-transplantation of human olfactory ensheathing cells with neurotrophin-3 into spinal cord cysts is more...

    O. V. Stepanova, G. A. Fursa, ... V. P. Chekhonin in Bulletin of Experimental Biology and Medicine
    Article 01 March 2024
  3. H2S-RhoA/ROCK Pathway and Glial Cells in Axonal Remyelination After Ischemic Stroke

    Ischemic stroke is one of the main reasons of disability and death. Stroke-induced functional deficits are mainly due to the secondary degeneration...

    Weizhuo Lu, Jiyue Wen in Molecular Neurobiology
    Article 15 June 2023
  4. Signaling mechanisms involved in the regulation of remyelination in multiple sclerosis: a mini review

    Multiple sclerosis is an autoimmune neurodegenerative disease of the CNS that causes progressive disabilities, owing to CNS axon degeneration as a...

    Midhuna Devanand, Saiprabha V.N., Krishnadas Madhu in Journal of Molecular Medicine
    Article 21 April 2023
  5. Impact of calcitriol and PGD2-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination

    Multiple sclerosis (MS) is a demyelinating and inflammatory disease of the central nervous system (CNS) in need of a curative treatment. MS research...

    Ariane Mwema, Viridiane Gratpain, ... Anne des Rieux in Drug Delivery and Translational Research
    Article 16 February 2024
  6. The interplay of inflammation and remyelination: rethinking MS treatment with a focus on oligodendrocyte progenitor cells

    Background

    Multiple sclerosis (MS) therapeutic goals have traditionally been dichotomized into two distinct avenues: immune-modulatory-centric...

    Omri Zveik, Ariel Rechtman, ... Adi Vaknin-Dembinsky in Molecular Neurodegeneration
    Article Open access 12 July 2024
  7. Inhibition of GPR17/ID2 Axis Improve Remyelination and Cognitive Recovery after SAH by Mediating OPC Differentiation in Rat Model

    Myelin sheath injury contributes to cognitive deficits following subarachnoid hemorrhage (SAH). G protein-coupled receptor 17 (GPR17), a membrane...

    Yingwen Wang, Anan Jiang, ... Zongduo Guo in Translational Stroke Research
    Article 07 November 2023
  8. Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody

    Failure of the immune system to discriminate myelin components from foreign antigens plays a critical role in the pathophysiology of multiple...

    Sara Grassi, Livia Cabitta, ... Alessandro Prinetti in Neurochemical Research
    Article 25 January 2023
  9. The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives

    Recent evidence suggests that the glucagon-like peptide-1 receptor (GLP-1R) agonists have neuroprotective activities in the CNS in animal models of...

    Marjan Gharagozloo, Danny Galleguillos, ... Peter A. Calabresi in Neurotherapeutics
    Article 09 June 2023
  10. Pyruvate Dehydrogenase-Dependent Metabolic Programming Affects the Oligodendrocyte Maturation and Remyelination

    The metabolic needs of the premature/premyelinating oligodendrocytes (pre-OLs) and mature oligodendrocytes (OLs) are distinct. The metabolic control...

    M. Sajad, Insha Zahoor, ... Shailendra Giri in Molecular Neurobiology
    Article 24 August 2023
  11. Microglial aryl hydrocarbon receptor enhances phagocytic function via SYK and promotes remyelination in the cuprizone mouse model of demyelination

    Multiple sclerosis (MS) is an inflammatory-mediated demyelinating disease of the central nervous system (CNS). Although studies have demonstrated...

    Yumeng Wang, **gxian Sun, ... Jun Wang in Journal of Neuroinflammation
    Article Open access 25 March 2023
  12. Electroacupuncture promotes remyelination and alleviates cognitive deficit via promoting OPC differentiation in a rat model of subarachnoid hemorrhage

    Subarachnoid hemorrhage (SAH) is a devastating cerebral vascular disease which causes neurological deficits including long-term cognitive deficit....

    Yingwen Wang, **aomin Yang, ... Yue Wu in Metabolic Brain Disease
    Article 16 November 2022
  13. MFG-E8 Alleviates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Phagocytosing Myelin Debris and Promoting Remyelination

    Chronic cerebral hypoperfusion is one of the pathophysiological mechanisms contributing to cognitive decline by causing white matter injury....

    **aohong Dong, Zhi Zhang, ... Yan Chen in Neuroscience Bulletin
    Article Open access 18 November 2023
  14. Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination

    Myelin loss with consecutive axon degeneration and impaired remyelination are the underlying causes of progressive disease in patients with multiple...

    Maria de los Angeles Castillo-Rodriguez, Stefan Gingele, ... Viktoria Gudi in Histochemistry and Cell Biology
    Article Open access 05 April 2022
  15. Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model

    Astrocytes display an active, dual, and controversial role in multiple sclerosis (MS), a chronic inflammatory demyelination disorder. However,...

    Soheila Madadi, Elham Shiri, ... Iraj Ragerdi Kashani in Molecular Neurobiology
    Article 29 September 2022
  16. Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination

    Glial cells play crucial roles in brain homeostasis and pathogenesis of central nervous system (CNS) injuries and diseases. However, the roles of...

    Lili Quan, Akiko Uyeda, Rieko Muramatsu in Inflammation and Regeneration
    Article Open access 02 March 2022
  17. Lipocalin-2-Mediated Insufficient Oligodendrocyte Progenitor Cell Remyelination for White Matter Injury After Subarachnoid Hemorrhage via SCL22A17 Receptor/Early Growth Response Protein 1 Signaling

    Insufficient remyelination due to impaired oligodendrocyte precursor cell (OPC) differentiation and maturation is strongly associated with...

    Qiang Li, Xufang Ru, ... Hua Feng in Neuroscience Bulletin
    Article Open access 07 July 2022
  18. Visualizing Sphingosine-1-Phosphate Receptor 1(S1P1) Signaling During Central Nervous System De- and Remyelination

    Multiple sclerosis (MS) is an inflammatory-demyelinating disease of the central nervous system (CNS) mediated by aberrant auto-reactive immune...

    Ezzat Hashemi, Ezra Yoseph, ... May H. Han in Cellular and Molecular Neurobiology
    Article 02 August 2022
  19. Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination

    Background

    Epigenetic regulation by histone deacetylases (HDACs) in Schwann cells (SCs) after injury facilitates them to undergo de- and...

    Anjali Yadav, Tzu-Chieh Huang, ... Chia-Ching Wu in Journal of Neuroinflammation
    Article Open access 16 October 2021
  20. Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders

    Oligodendrocyte precursor cells (OPCs) are present in demyelinated lesions of multiple sclerosis (MS) patients. However, their differentiation into...

    Karin Mausner-Fainberg, Moshe Benhamou, ... Arnon Karni in Neurotherapeutics
    Article 22 June 2021
Did you find what you were looking for? Share feedback.